UY34475A - Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen - Google Patents

Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Info

Publication number
UY34475A
UY34475A UY0001034475A UY34475A UY34475A UY 34475 A UY34475 A UY 34475A UY 0001034475 A UY0001034475 A UY 0001034475A UY 34475 A UY34475 A UY 34475A UY 34475 A UY34475 A UY 34475A
Authority
UY
Uruguay
Prior art keywords
hexahydrociclopenta
propoxi
benzamida
pirrol
antagonist
Prior art date
Application number
UY0001034475A
Other languages
English (en)
Inventor
Merdes Annette
Sors Aurore
Caryn Trocme-Thibierge
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47682151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY34475(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of UY34475A publication Critical patent/UY34475A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1H)-il]propoxi}benzamida de fórmula (I): o una de sus sales de adición a un ácido o a una base farmacéuticamente aceptable, y un antagonista de los receptores glutamatérgicos NMDA. Medicamentos.
UY0001034475A 2011-12-09 2012-11-28 Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen UY34475A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161568831P 2011-12-09 2011-12-09
FR1103777A FR2983732B1 (fr) 2011-12-09 2011-12-09 Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
UY34475A true UY34475A (es) 2013-07-31

Family

ID=47682151

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034475A UY34475A (es) 2011-12-09 2012-11-28 Nueva asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1h)-il] propoxi}benzamida y un antagonista de los receptores nmda y las composiciones farmacéuticas que la contienen

Country Status (28)

Country Link
US (2) US8921409B2 (es)
EP (1) EP2601942A1 (es)
JP (1) JP5591310B2 (es)
KR (1) KR101489670B1 (es)
CN (1) CN103157111B (es)
AP (1) AP3225A (es)
AR (1) AR089112A1 (es)
AU (1) AU2012258339A1 (es)
BR (1) BR102012031031A2 (es)
CA (1) CA2798549A1 (es)
CL (1) CL2012003437A1 (es)
CO (2) CO6660080A1 (es)
CR (1) CR20120608A (es)
EA (1) EA201201530A1 (es)
EC (1) ECSP12012329A (es)
FR (1) FR2983732B1 (es)
GT (1) GT201200329A (es)
MA (1) MA34867B1 (es)
MD (1) MD4348B1 (es)
MX (1) MX2012014184A (es)
NI (1) NI201200178A (es)
PE (1) PE20130813A1 (es)
PH (1) PH12012000378A1 (es)
SG (1) SG191494A1 (es)
TN (1) TN2012000563A1 (es)
TW (1) TWI457123B (es)
UY (1) UY34475A (es)
WO (1) WO2013083887A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3003466B1 (fr) * 2013-03-22 2015-08-07 Servier Lab Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
KR101484405B1 (ko) * 2013-08-14 2015-01-19 서울대학교산학협력단 Ｎｉｎｊｕｒｉｎ１ 결핍 유래의 강박증 예방 또는 치료용 약학적 조성물
GB201509134D0 (en) * 2015-05-28 2015-07-15 Electrophoretics Ltd Biomolecules involved in Alzheimer's disease
EP4484953A3 (en) * 2015-07-22 2025-03-12 Anavex Life Sciences Corp. Enantiomers of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine (anavex2-73) and use thereof in the treatment of alzheimer's disease and other disorders modulated by the sigma 1 receptor

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1509232B1 (en) * 2002-05-31 2008-11-19 H. Lundbeck A/S A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
MXPA05012493A (es) * 2003-05-27 2006-05-25 Forest Laboratories Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
EP1638560A1 (en) * 2003-06-20 2006-03-29 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
AU2005204358B2 (en) * 2004-01-05 2008-09-04 Merz Pharma Gmbh & Co. Kgaa Memantine for the treatment of mild and mild-to-moderate Alzheimer's disease
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200531680A (en) * 2004-03-03 2005-10-01 Merz Pharma Gmbh & Co Kgaa Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
US20070213388A1 (en) * 2004-03-19 2007-09-13 Bruinsma Gosse B Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Antagonists Useful in the Treatment of of Cognitive Disorders
FR2937119B1 (fr) 2008-10-15 2010-12-17 Air Liquide Procede de production d'energie et capture de co2
FR2937251B1 (fr) * 2008-10-16 2011-03-18 Servier Lab Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953515B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NI201200178A (es) 2013-05-13
CA2798549A1 (fr) 2013-06-09
FR2983732B1 (fr) 2013-11-22
PH12012000378A1 (en) 2015-09-11
AP2012006607A0 (en) 2012-12-31
BR102012031031A2 (pt) 2013-10-29
US20130150421A1 (en) 2013-06-13
KR101489670B1 (ko) 2015-02-04
CO6690116A1 (es) 2013-06-17
EA201201530A1 (ru) 2013-07-30
JP5591310B2 (ja) 2014-09-17
AR089112A1 (es) 2014-07-30
CO6660080A1 (es) 2013-04-30
TW201334777A (zh) 2013-09-01
AU2012258339A1 (en) 2013-06-27
AP3225A (en) 2015-04-30
SG191494A1 (en) 2013-07-31
WO2013083887A1 (fr) 2013-06-13
US8921409B2 (en) 2014-12-30
FR2983732A1 (fr) 2013-06-14
CL2012003437A1 (es) 2014-01-24
CN103157111A (zh) 2013-06-19
CR20120608A (es) 2014-03-05
MX2012014184A (es) 2013-06-18
TWI457123B (zh) 2014-10-21
MD4348B1 (ro) 2015-05-31
JP2013121956A (ja) 2013-06-20
KR20130065602A (ko) 2013-06-19
PE20130813A1 (es) 2013-07-28
ECSP12012329A (es) 2013-01-31
EP2601942A1 (fr) 2013-06-12
TN2012000563A1 (fr) 2014-04-01
US20150080448A1 (en) 2015-03-19
WO2013083887A8 (fr) 2013-08-08
NZ604084A (en) 2014-07-25
MA34867B1 (fr) 2014-02-01
GT201200329A (es) 2014-03-14
CN103157111B (zh) 2015-02-11

Similar Documents

Publication Publication Date Title
UY34220A (es) Indazoles, composiciones farmacéuticas y uso de los mismos
CR20140106A (es) Compuestos y composiciones como inhibidores de la quinasa c-kit
CO2017002532A2 (es) Indazoles sustituidos con bencilo como inhibidores de bub1
UY34138A (es) Antagonistas de trpv4
MX2015013042A (es) Compuestos organicos.
UY34212A (es) Derivados de piridin-2(1h)-ona como inhibidores de jak
UY34111A (es) Nuevos co-cristales de agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP13013074A (es) Nuevos derivados de piridina
UY33958A (es) Inhibidores de la glucosilceramida sintasa
UY34550A (es) Bencilpirazoles sustituidos
UY34800A (es) Combinaciones farmacéuticas que contienen un inhibidor de 11-beta-hidroxiesteroide dehidrogenasa-1 útil en trastornos metabólicos
UY34538A (es) Heteroarilos y usos de los mismos
UY33930A (es) Inhibidores novedosos de quinasas
UY34365A (es) Compuestos heterociclicos
UY34561A (es) Compuestos dímeros agonistas de los receptores de los fgf (fgfr), su procedimiento de preparación y su aplicación en terapéutica.
UY34094A (es) Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
UY34541A (es) ?derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina?.
UY34572A (es) Compuestos heterocíclicos agonistas del receptor ip
UY34197A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY34198A (es) NUEVOS ANTAGONISTAS DE CRTh2
UY33906A (es) Composiciones herbicidas que comprenden topramezona
UY33957A (es) Moduladores de los receptores de hormonas nucleares
UY34482A (es) Composiciones y métodos para mejorar la calidad de los espermatozoides procesados
UY34193A (es) Aparato para medir un objeto
CR20150210A (es) Nuevos derivados de pirazina como agonistas receptores de cb2